AstraZeneca’s Profit Gains on Sales of Cancer Drugs
(Bloomberg) -- AstraZeneca Plc shares surged after the UK drugmaker reported profit that outpaced expectations, buoyed by demand for its cancer blockbusters Imfinzi and Tagrisso as well as newcomer Enhertu. The stock rose as much as 6.5% in London trading …